OP Asset Management Ltd Takes Position in UnitedHealth Group Incorporated $UNH

OP Asset Management Ltd acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the first quarter, Holdings Channel.com reports. The firm acquired 159,328 shares of the healthcare conglomerate’s stock, valued at approximately $43,113,000.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Brighton Jones LLC lifted its holdings in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH acquired a new position in UnitedHealth Group during the second quarter worth about $340,000. Flow Traders U.S. LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $356,000. Finally, Jump Financial LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $377,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Bank of America raised its price target on UnitedHealth Group to $475 from $450 and reiterated a buy rating, signaling additional upside from current levels. Benzinga article on price target increase
• Positive Sentiment: Multiple articles highlighted UnitedHealth Group as a top long-term value stock, which may be supporting sentiment among growth-at-a-reasonable-price investors. Zacks article on long-term value stock
• Positive Sentiment: Commentary from Jim Cramer recommending UNH as a buy added to the upbeat tone around the stock. Motley Fool article on Jim Cramer
• Positive Sentiment: UNH also reached a proposed FTC settlement over insulin rebating practices, which could reduce regulatory uncertainty if finalized. Yahoo Finance article on FTC settlement
• Neutral Sentiment: Several additional pieces described UnitedHealth as steady in healthcare or discussed whether it is a buy, but did not add a major new catalyst beyond the generally favorable sentiment. Kalkine Media article on steady performance

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. The trade was a 4.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of UNH opened at $405.86 on Thursday. The firm’s 50 day moving average price is $379.62 and its 200 day moving average price is $331.17. The company has a market cap of $368.58 billion, a P/E ratio of 30.65, a PEG ratio of 1.65 and a beta of 0.64. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $415.98.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. During the same period last year, the business posted $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were given a dividend of $2.32 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio is presently 70.09%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Cantor Fitzgerald restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Barclays upped their price objective on shares of UnitedHealth Group from $373.00 to $429.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. Jefferies Financial Group increased their price target on shares of UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a research note on Monday, April 20th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective for the company in a research report on Tuesday, April 7th. Finally, Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price objective for the company in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $410.79.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.